A Multicenter Adaptive Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
Brief description of study
This study will compare the effect of giving remdesivir in combination with baricitinib and a placebo infusion or remdesivir in combination with dexamethasone and a placebo tablet in adult patients that are hospitalized with COVID-19. The drugs have been tested before in humans with COVID-19 and other diseases. This study will examine whether these drugs are safe for use in humans with COVID-19 and see if they together can improve patients health when they are sick with COVID-19.
Clinical Study Identifier: s20-00286
ClinicalTrials.gov Identifier: NCT04640168
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
